To evaluate the effect of meal replacement therapy on glucose control and other metabolic parameters in patients with uncontrolled type 2 diabetes.
Methodology:
This is an open-label, prospective, randomized control trial study. Study duration. August 2023 - March 2026. Study location. This study will be conducted at the Klinik Rawatan Keluarga and diabetes clinic Hospital Universiti Sains Malaysia.
Source Reference :
People with type 2 diabetes mellitus attending the Hospital Universiti Sains Malaysia.
Study source population :
People with type 2 diabetes mellitus attended Klinik Rawatan Keluarga and diabetes clinic Hospital Universiti Sains Malaysia during the study period.
Patients between ≥ 30 to ≤ 65 years old
Diagnosed as having type 2 diabetes mellitus base on CPG Malaysia Clinical Practice Guidelines (CPG) for Type 2 Diabetes Mellitus (T2DM) 6th edition 2020.
On oral hypoglycaemic agent(s)
HbA1c 7- 10 % (result 3 months from the date of recruitment)
Severe diabetic complication(s) including end-stage renal disease and proliferative retinopathy.
Pregnancy or plan to get pregnant during the study period
Newly diagnosed diabetic less than 3 months from the date of recruitment
Currently involve in any weight loss program
Hospital Universiti Sains Malaysia
Lead sponsor
Ethos Healthcare Sdn Bhd company
Collaborator